Challenger (ASX:CGF) said Dai-ichi Life subsidiary, TAL Dai-ichi Life Australia, agreed to acquire a 15.1% minority interest in the company from MS&AD Insurance Group at 763 yen per share, according to a Monday filing with the Australian bourse.
The share sale is subject to regulatory approvals from the Australian Foreign Investment Review Board and the Australian Prudential Regulation Authority, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.